You need to enable JavaScript to run this app.
WHO issues guidance on nitrosamine controls in drug manufacturing
Regulatory News
Emily Hayes
APIs
Generics
Global
GMP
Manufacturing
Nitrosamines
Pharmaceuticals
Product Lifecycle